Powered by

AGC announces acquisition of MPC to obtain another manufacturing and sales base outside of Japan

Mar 04, 2019 - Global Banking News
Mergers and Acquisitions

Japanese drug discovery company AGC Inc revealed on Monday the completion of the acquisition of the synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals SLU (MPC), based out of Spain.

MPC reportedly meets cGMP standards as well as a production site with a strong track record that is designed to handle diverse scales needed, from development-phase to commercial-stage pharmaceuticals.

Following the acquisition of MPC, AGC will now manufacture and process in...